MiMedx Comments on CMS Release of CY 2026 Physician Fee Schedule Final Rule

Strategic Insights -

The Centers for Medicare and Medicaid Services (CMS) has released the CY 2026 Physician Fee Schedule (PFS) final rule, which has significant implications for the healthcare industry, particularly for companies producing skin substitutes. MiMedx Group, Inc., a leading provider of healing solutions, has been actively engaged with stakeholders to advocate for reform in the Medicare reimbursement system. According to Joseph H. Capper, MiMedx Chief Executive Officer, the CMS's actions will help reduce fraud, waste, and abuse in the industry, restoring a more rational behavior to the market.

Key Takeaways:

  • MiMedx has been actively engaging with stakeholders to advocate for reform in the Medicare reimbursement system for skin substitutes, resulting in the CMS's release of the CY 2026 PFS final rule.
  • The final rule is essentially what was proposed in July, providing a large opportunity for MiMedx given its competitive advantages, including fully integrated operations, a proprietary commercial organization, best-in-class technology, and a robust I.P. portfolio.
  • MiMedx has been preparing for a range of potential outcomes regarding reimbursement reform and believes that this final rule will help restore stability and predictability to the market.
  • The Company's highest priority during the transition is to ensure patients have continued access to its proven technology.
  • MiMedx will leverage its strengths to gain share as the market adjusts to the new reimbursement environment.

Statistics:

  • The CMS has released the CY 2026 PFS final rule, which will have significant implications for the healthcare industry.
  • MiMedx has been engaged with stakeholders for several years to advocate for reform in the Medicare reimbursement system.
  • The Company has a large and proprietary commercial organization, with a robust and defensible I.P. portfolio.
  • MiMedx has a strong balance sheet and best-in-class technology.

Sources:

  • GLOBE NEWSWIRE, "MiMedx Group, Inc. Comments on CMS Release of CY 2026 Physician Fee Schedule Final Rule", November 3, 2025.